Galderma buys ZO Skin Health for US$1.5B to expand dermatological skin care
Galderma has signed an agreement to acquire all of ZO Skin Health for US$1.5 billion from its shareholders, including funds managed by Blackstone Tactical Opportunities and the Obagi family. ZO Skin Health has a product portfolio of over 40 products, such as cleansers, serums, exfoliators, and toners. The physician-dispensed skin care brand is built on clinical science and protocol-based daily care.This Technical Paper is brought to you by Ashland.
Azitra co-founder and chief operating officer Travis Whitfill, discusses the company’s development of functional human filaggrin for topical skin care applications. The biotech-designed protein is engineered for stability and skin penetration, helping support the skin barrier, hydration, and pH balance. Whitfill also shares recent ex vivo findings on skin elasticity, plans for clinical testing on fine lines and wrinkles, and the growing role of biotechnology and the skin microbiome in skin care.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

Next-level “skinification” Oct 2026

Sustainable beauty solutionsOct 2026
Multimedia
Azitra co-founder and chief operating officer Travis Whitfill, discusses the company’s development of functional human filaggrin for topical skin care applications. The biotech-designed protein is engineered for stability and skin penetration, helping support the skin barrier, hydration, and pH...





























